Fosetyl-Al stem injection for chestnut ink disease management: efficacy and dose-dependent phytotoxicity in saplings

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Fosetyl-Al (aluminium tris-(ethyl phosphonate)) is a low-toxicity phosphonate commonly used to control oomycete-related diseases in crops. Trunk injection (endotherapy) delivers the fungicide directly into the vascular system, potentially improving efficacy while reducing off-target losses. This two-year study evaluated the efficacy and phytotoxicity of stem-injected fosetyl-Al to manage ink disease caused by Phytophthora cinnamomi in Castanea sativa saplings. Fifty saplings received fosetyl-Al injections at 0–4% using pressurized devices, followed by stem inoculation with the pathogen; a 2% soil irrigation treatment was included for comparison. Stem injections at 1%, 2% and 4% significantly suppressed stem necrosis after inoculation with P. cinnamomi and reduced root infections compared to irrigation and untreated control. Protection persisted for at least two years as reflected by reduced relative Area Under the Disease Progress Curve (rAUDPC) values. However, stem injections also induced phytotoxic symptoms, including leaf burn, necrosis, and occasional plant death, with a clear dose-dependent relationship. Most plants recovered from moderate phytotoxicity, whereas irreversible damage occurred at the highest doses, highlighting the critical need for precise dose adjustments, particularly in small-diameter trees. Logistic regression identified a Minimum Effective Dose (MED) range of 0.061–0.102 g/cm (a.i.) of stem circumference, corresponding to predicted disease incidence thresholds of < 10% to < 1%, respectively, with associated phytotoxicity risks of approximately 10–25%. These results indicate that trunk injection of fosetyl-Al can provide effective and targeted control of ink disease in young chestnut plants under the conditions tested, while emphasizing the need for dose optimization to minimize adverse effects.

Article activity feed